Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
Volume Reduction and Process Optimization with Cadence Inline Concentrator
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
View All Featured ArticlesHeadline News
Lilly unveils Change the Course Commitment aimed at closing diabetes and obesity treatment gaps in lower-income countries
AstraZeneca commits $2 billion to Summit Therapeutics as part of new equity stake and cancer research alliance centered on antibody drug conjugate combinations
Pfizer to showcase new cancer research spanning current standards of care and emerging pipeline breakthroughs at ESMO 2026
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Next Generation Manufacturing at Biogen – PAT as an Enabler for Enhanced Process
Presented by Oliver Steinhof, PAT Scientist at Biogen and Martin Gadsby, Owner, Optimal Industrial Automation Ltd
06th November 2020
New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process
Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche and Mathilde Arnault, Research Scientist, BioMonitoring R&D, Merck KGaA, Darmstadt, Germany
09th April 2019
Making Virus Inactivation a Reality for Continuous Upscaled Processes
Presented by Mark Schofield, Ph.D., Principal R&D Engineer, Pall Life Sciences - Westborough, MA, USA
30th November 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Column Packing Protocol for Amsphere A3
Best Practices for Achieving Virus Safety
Amsphere TM A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
